Author information from the last article
Giske Ursin er cand.med., ph.d., direktør ved Kreftregisteret, professor II ved Avdeling for ernæringsvitenskap, Universitetet i Oslo og professor emerita ved University of Southern California.
Articles by Giske Ursin
Inequalities in colorectal cancer screening uptake
- Paula Berstad,
- Anna Lisa Schult,
- Geir Hoff,
- Giske Ursin,
- Kristin Ranheim Randel
27.03.2023:
Participation in colorectal screening varies between different sociodemographic groups. In a colorectal cancer screening trial (Bowel Cancer Screening in Norway (BCSN)), participation has been compared over the past ten years among those who were screened at home and those who attended hospital for...
Cancer trends and population structure in Norway 1990–2016
- Kirsti Vik Hjerkind,
- Inger Kristin Larsen,
- Bjørn Møller,
- Giske Ursin
22.11.2018:
Since 1953 we have had a near-complete overview of cancer incidence in Norway, and the incidence rates for all types of cancer as a whole are nearly twice as high today as they were 60 years ago. Since we started registration of cancer, the population has increased by nearly two million, and there...
Sigmoidoscopy and faecal occult blood test – a comparative screening trial
- Thomas de Lange,
- Kristin Ranheim Randel,
- Anna Lisa Schult,
- Markus Dines Knudsen,
- Benedicte Kirkøen,
- Edoardo Botteri,
- Paula Berstad,
- Anita Jørgensen,
- Giske Ursin,
- Michael Bretthauer,
- Geir Hoff
23.05.2017:
Colorectal cancer is a major health issue, both globally and in Norway. Bowel cancer screening is perhaps the most effective method to mitigate the consequences of the disease for patients and society. Large-scale randomised trials show that screening with sigmoidoscopy and faecal occult blood tests...